文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常综合征的遗传学

Genetics of MDS.
PubMed 文献 · Blood · 2019-01-22

综述回顾了近十年测序技术推动下骨髓增生异常综合征(MDS)遗传学进展,揭示了DNA甲基化、染色质修饰、RNA剪接、转录、信号转导、黏连蛋白调控和DNA修复等驱动突变谱,强调突变与临床表型、药物反应和预后相关,并讨论了与急性髓系白血病及年龄相关克隆性造血的重叠及克隆演化。

要点

  • MDS常见驱动突变涉及DNA甲基化、染色质修饰、RNA剪接、转录、信号转导、黏连蛋白调控和DNA修复等通路。
  • MDS驱动突变与急性髓系白血病及健康个体年龄相关克隆性造血存在大量重叠,推测具有共同克隆起源。
  • 突变与特定疾病表型、药物反应和临床结局相关,熟悉MDS遗传学对优化患者管理至关重要。

核心结论

  • 过去十年对MDS及相关髓系疾病遗传学的认识显著提高,测序技术革新发挥主要作用。
  • 已揭示在可识别比例MDS患者中反复出现的驱动突变综合目录,并正努力阐明其对临床表型、预后及MDS发病机制的影响。
  • 突变被认为以有序方式获得并正选择,使起始克隆扩增并损害正常造血,最终导致MDS及许多患者后续转化为急性髓系白血病。

研究设计与样本

  • 综述,旨在简要概述MDS遗传学近期进展。

主要发现

  • MDS主要突变靶标包括参与DNA甲基化、染色质修饰、RNA剪接、转录、信号转导、黏连蛋白调控和DNA修复的分子。
  • MDS驱动突变与急性髓系白血病及健康个体年龄相关克隆性造血所见驱动突变存在大量重叠,推测具有共同克隆起源。
  • 突变间显著相关性提示存在功能相互作用,决定疾病进展。
  • 突变常与特定疾病表型、药物反应和临床结局相关。

临床怎么用

  • 作者认为,熟悉MDS遗传学对于更好地管理患者至关重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our knowledge about the genetics of myelodysplastic syndromes (MDS) and related myeloid disorders has been dramatically improved during the past decade, in which revolutionized sequencing technologies have played a major role. Through intensive efforts of sequencing of a large number of MDS genomes, a comprehensive registry of driver mutations recurrently found in a recognizable fraction of MDS patients has been revealed, and ongoing efforts are being made to clarify their impacts on clinical phenotype and prognosis, as well as their role in the pathogenesis of MDS. Among major mutational targets in MDS are the molecules involved in DNA methylations, chromatin modification, RNA splicing, transcription, signal transduction, cohesin regulation, and DNA repair. Showing substantial overlaps with driver mutations seen in acute myeloid leukemia (AML), as well as age-related clonal hematopoiesis in healthy individuals, these mutations are presumed to have a common clonal origin. Mutations are thought to be acquired and positively selected in a well-organized manner to allow for expansion of the initiating clone to compromise normal hematopoiesis, ultimately giving rise to MDS and subsequent transformation to AML in many patients. Significant correlations between mutations suggest the presence of functional interactions between mutations, which dictate disease progression. Mutations are frequently associated with specific disease phenotype, drug response, and clinical outcomes, and thus, it is essential to be familiar with MDS genetics for better management of patients. This review aims to provide a brief overview of the recent progresses in MDS genetics.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Ogawa S. Genetics of MDS. Blood. 2019. PMID: 30670442. doi:10.1182/blood-2018-10-844621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。